Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) just unveiled an update.
Shanghai Pharmaceuticals Holding Co., Ltd. has announced a final cash dividend of RMB 2.9 per 10 shares for the financial year ending December 31, 2024. The announcement includes details on withholding tax rates for different types of shareholders, emphasizing the company’s commitment to shareholder returns. The dividend is subject to shareholder approval on June 26, 2025, and further details regarding the payment date and currency will be announced later.
The most recent analyst rating on (HK:2607) stock is a Buy with a HK$15.70 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is a significant player in the Chinese market, offering a wide range of medical and healthcare products.
Average Trading Volume: 5,337,783
Technical Sentiment Signal: Sell
Current Market Cap: HK$65.5B
For an in-depth examination of 2607 stock, go to TipRanks’ Stock Analysis page.